logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


20 New IPOs for Week of July 28

By  +Follow July 28, 2014 1:53PM
Share:
Tickers Mentioned:

Full IPO calendar & reports HERE.  In order of largest IPO first:

 

(1) Based in Stamford, CT, Synchrony Financial (SYF) scheduled a $3.06 billion IPO on the NYSE with a market capitalization of $20.3 billion at a price range midpoint of $24 for Thursday, July 31, 2014.

SYF is one of the premier consumer financial services companies in the United States. It's the old GE Capital.

 

(2) Based in Somerset, NJ, Catalent (CTLT) scheduled a $871 million IPO on the NYSE with a market capitalization of $2.4 billion at a price range midpoint of $20.50 for Thursday, July 31, 2014.

CTLT is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.

 

(3) Based in Jerusalem, Israel, Mobileye N.V. (MBLY) scheduled a $500 million IPO on the NYSE with a market capitalization of $3.8 billion at a price range midpoint of $18 for Friday, August 1, 2014.

MBLY is the global leader in the design and development of software and related technologies for camera-based Advanced Driver Assistance Systems (“ADAS”).

 

(4) Based in London, United Kingdom, VTTI Energy Partners LP  (VTTI) scheduled a $350 million IPO on the NYSE, with a market capitalization of $402 million at a price range midpoint of $20 for Friday, August 1, 2014.

VTTI is a fee-based, growth-oriented limited partnership formed in April 2014 by VTTI, one of the world’s largest independent energy terminaling businesses, to own, operate, develop and acquire refined petroleum product and crude oil terminaling and related energy infrastructure assets on a global scale.

 

(5) Based in Aberdeen, United Kingdom,Transocean Partners (RIGP) scheduled a $350 million IPO on the NYSE with a market capitalization of $827 million at a price range midpoint of $20 for Thursday, July 31, 2014.

RIGP is a growth-oriented limited liability company recently formed by Transocean,one of the world’s largest offshore drilling contractors, to own, operate and acquire modern, technologically advanced offshore drilling rigs.

 

(6) Based in Houston, TX, Westlake Chemical Partners LP (WLKP) scheduled a $225 million IPO on the NYSE with a market capitalization of $508 milliion at a price range midpoint of $20 for Wednesday, July 30, 2014.

WLKP is a Delaware limited partnership recently formed by Westlake to operate, acquire and develop ethylene production facilities and related assets.

 

(7) Based in Weston, FL, FCB Financial Holdings (FCB) scheduled a $223 million IPO on the NYSE with a market capitalization of $1.02 billion at a price range midpoint of $25.50 for Friday, August 1, 2014.

 

(8) Based in Oakbrook Terrace, IL, SIRVA (SRVA) scheduled a $186 million IPO on the Nasdaq with a market capitalization of $632 million at a price range midpoint of $16 for Friday, August 1, 2014.

SRVA is a moving/relocation company.

 

(9) Based in North Billerica, MA, Lantheus Holdings (LNTH) scheduled a $125 million IPO on the Nasdaq with a market capitalization of $370 million at a price range midpoint of $13.50 for Wednesday, July 30, 2014.

LNTH is a global leader in developing, manufacturing, selling and distributing innovative diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases.

 

(10) Based in Draper, UT, Health Equity (HQY) scheduled a $100 million IPO on the Nasdaq with a market capitalization of $546 million at a price range midpoint of $11 for Thursday, July 31, 2014.

HQY is a leader and an innovator in the high growth category of technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions.

 

(11) Based in Or Yehuda, Israel, Vascular Biogenics (VBLX) scheduled a $76 million IPO on the Nasdaq with a market capitalization of $259 million at a price range midpoint of $14 for Thursday, July 31, 2014.

VBLX is a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of first-in-class treatments for cancer and immune-inflammatory diseases.

 

(12) Based in Menlo Park, CA, Avalanche Biotechnologies (AAVL) scheduled a $76 million IPO on the Nasdaq with a market capitalization of $292 million at a price range midpoint of $14 for Thursday, July 31, 2014.

AAVL is a clinical-stage biotechnology company focused on discovering and developing novel gene therapies to transform the lives of patients with sight-threatening ophthalmic diseases.

 

(13) Based in Zug, Switzerland, Auris Medical Holding AG (EARS) scheduled a $76 million IPO on the Nasdaq with a market capitalization of $283 million at a price range midpoint of $11 for Friday, August 1, 2014.

EARS is a clinical-stage biopharmaceutical company focused on the development of novel products for the treatment of inner ear disorders.

 

(14) Based in Petach Tikva, Israel, Macrocure (MCUR) scheduled a $75 million IPO on the Nasdaq with a market capitalization of $264 million at a price range midpoint of $14 for Thursday, July 31, 2014.

MCUR is a regenerative medicine company focused on developing, manufacturing and commercializing novel cell therapy products to address unmet needs in the treatment of chronic and other hard-to-heal wounds.

 

(15) Based in Fremont, CA, Zosano Pharma (ZSAN) scheduled a $70 million IPO on the Nasdaq with a market capitalization of $134 million at a price range midpoint of $11 for $134 million for the week of July 28th.

ZSAN is a clinical stage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver its proprietary formulations of existing drugs through the skin for the treatment of a variety of indications.

 

(16) Based in South San Francisco, CA, Tobira Therapeutics (TBRA) scheduled a $60 million IPO on the Nasdaq with a market capitalization of $143 million at a price range midpoint of $13 for Thursday, July 31, 2014.

TBRA is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat liver disease, human immunodeficiency virus, or HIV, fibrosis and inflammation.

 

(17) Based in Stamford, CT, Loxo Oncology (LOXO) scheduled a $57 million IPO on the Nasdaq with a market capitalization of $196 million at a price range midpoint of $13 for Friday, August 1, 2014.

LOXO develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations.

 

(18) Based in New Haven, CT, Marinus Pharmaceuticals (MRNS) scheduled a $52 million IPO on the Nasdaq with a market capitalization of $159 million at a price range midpoint of $13 for Thursday, July 31, 2014.

MRNS is a clinical stage biopharmaceutical company focused on developing and commercializing innovative neuropsychiatric therapeutics.

 

(19) Based in Tel Aviv, Israel, Bio Blast Pharma Ltd. (ORPN) scheduled a $40 million IPO on the Nasdaq with a market capitalization of $172 million at a price range midpoint of $172 for Friday, Aug. 1, 2014.

ORPN is a development-stage biopharmaceutical company focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases.

 

(20) Based in Yonker, NY, ContraFect (CFRXU) scheduled a $20 million IPO on the Nasdaq with a market capitalization of $96 million at a price range midpoint of $5.50 for Tuesday, July 29, 2014.

CFRXU is a biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Signup for our daily newsletter and get our best articles emailed right to you!

Results for SYF
Dakota Financial
6 Jul 15 05:39:56
Morningstar Gives “BBB” Credit Rating to Synchrony Financial $SYF http://t.co/aEcr5CoIvR
ProTradersNews
6 Jul 15 05:29:03
$SYF: Morningstar Gives "BBB" Credit Rating to Synchrony Financial (SYF): http://t.co/f6G1IMkkYL
Zonebourse News
4 Jul 15 22:48:06
#SYNCHRONY FINANCIAL : Premier semestre 2015 Présentation des résultats http://t.co/zCHNSPqoPk $SYF
Zonebourse News
4 Jul 15 22:48:06
#SYNCHRONY FINANCIAL : Premier semestre 2015 Publication de résultats http://t.co/zCHNSPqoPk $SYF
ProVesting
4 Jul 15 07:29:03
$SYF: Brokerages Set Synchrony Financial PT at $33.05 (NYSE:SYF): http://t.co/4tXXDb3Vti
Dakota Financial
4 Jul 15 07:24:00
Brokerages Set Synchrony Financial PT at $33.05 $SYF http://t.co/xm1AB6lvIf
Analyst Actions
3 Jul 15 08:29:02
$SYF: Analyst action by Guggenheim Securities on Synchrony Financial: http://t.co/mCYbazUsS6 http://t.co/6xtofQdYAj
StockNewsWires
2 Jul 15 13:40:05
$SYF: New Insider Transaction on SYF by Director: http://t.co/HX8OHAdDfc
Insider Alerts
2 Jul 15 13:39:06
NEW insider transaction on $SYF reported a moment ago: http://t.co/oOLtiT3lM3
DailyStockPicks
2 Jul 15 09:05:25
$NVDA acquiring TransGaming Assets, values $TNSGF $TNG.V at 300%+ upside, 25 cents $SYF $CTAS $TS investors read http://t.co/M6ATjY2Anp
Breaking News Now
1 Jul 15 12:44:04
$SYF: Value Stock Watch: Synchrony Financial (NYSE:SYF): http://t.co/2G4mgwBVtB
Ticker Report
1 Jul 15 08:26:43
Synchrony Financial Receives Consensus Rating of “Buy” from Analysts $SYF http://t.co/qYEFnuPfLH
Sleek Money
1 Jul 15 08:20:46
Synchrony Financial Receives Consensus Rating of “Buy” from Analysts $SYF http://t.co/JeWqLzjwqK
WKRB News
1 Jul 15 06:36:26
Synchrony Financial Earns Buy Rating from Analysts at Guggenheim $SYF http://t.co/vd5JBer3li
Sleek Money
1 Jul 15 05:35:47
Morningstar Gives BBB Credit Rating to Synchrony Financial $SYF http://t.co/6GEGBQwE2G
Ticker Report
1 Jul 15 05:27:11
Morningstar Gives BBB Credit Rating to Synchrony Financial $SYF http://t.co/vDSjOrlVwG
Breaking News
1 Jul 15 03:49:02
$SYF: Synchrony Financial (NYSE:SYF) Analyst Rating Update: http://t.co/te1kTt6l9z
SwingTradeBot
30 Jun 15 14:39:45
Scan results - Expansion Pivot Buy Setup today: $THS $XYL $AGU $SBH $PSX $CLLS $OPHT $SYF $CMGE ... http://t.co/3T2A9vQ1yL
Analyst Actions
30 Jun 15 10:51:01
$SYF: Analyst action by Guggenheim Securities on Synchrony Financial: http://t.co/mCYbazUsS6 http://t.co/Xs4T8N5cph
Breaking News
30 Jun 15 07:57:03
$SYF: Synchrony Financial to Announce Second Quarter 2015 Financial ...: http://t.co/YEvYCKH5gY
SWINGSTOCKTRADERS
30 Jun 15 07:51:14
BUY $SYF at Price: 32.80 Stop: 32.14, Loss: 2% Target T1: 35.40, Profit: 7.9% http://t.co/sqRlD1MPJl
The Legacy News
30 Jun 15 04:42:49
Synchrony Financial Now Covered by Guggenheim $SYF http://t.co/VqLPD2oBVI
Quantpost Industrial
30 Jun 15 04:01:28
$GE News: "GE Capital Is Getting Smaller By The Day $ALSMY $SYF $GE" http://t.co/DSNwJbTMUC Analyze: https://t.co/AWFrR7Ysdg
Long & Short Ideas
30 Jun 15 04:01:26
GE Capital Is Getting Smaller By The Day http://t.co/zNHrNQaAf5 $ALSMY $SYF $GE
Quantpost $GE
30 Jun 15 04:01:26
$GE News: "GE Capital Is Getting Smaller By The Day $ALSMY $SYF $GE" http://t.co/tXGTTv9AyN Analyze: https://t.co/SrUUMgJrIK
Seeking Alpha
30 Jun 15 04:01:26
GE Capital Is Getting Smaller By The Day http://t.co/CT2ZKlj1o6 $ALSMY $SYF $GE
ProVesting
29 Jun 15 19:01:46
$SYF: Shares of Synchrony Financial (NYSE:SYF) Sees Large Inflow of ...: http://t.co/G6V881XHb2
Dakota Financial
29 Jun 15 16:10:05
Synchrony Financial Coverage Initiated by Analysts at Guggenheim $SYF http://t.co/RZaujSfpX5
Sleek Money
29 Jun 15 16:09:53
Guggenheim Begins Coverage on Synchrony Financial $SYF http://t.co/EeVRd8P1if
Ticker Report
29 Jun 15 16:05:19
Guggenheim Begins Coverage on Synchrony Financial $SYF http://t.co/llwETDYO2N
Breaking News
29 Jun 15 15:51:04
$SYF: Synchrony Financial Coverage Initiated by Analysts at Guggenheim ...: http://t.co/wRjbYooaS3
FirstToMarkets
29 Jun 15 15:45:05
Synchrony Financial Initiated Coverage by Guggenheim Securities (Ranked 1st) to Buy $SYF #SYF http://t.co/Yk03MZjOY7
BreakingStocksNews
29 Jun 15 15:40:03
$SYF: Guggenheim Begins Coverage on Synchrony Financial (SYF): http://t.co/U3K4tB8Evt
Penny Stock Secret
29 Jun 15 12:08:22
The Most Accurate Stock Alert Service Made $240,000 Yesterday http://t.co/SVqoMkrw2z .. $SYF $SYK $SYT
				
				
By  +Follow July 28, 2014 1:53PM
Share:

Comments

 

blog comments powered by Disqus

 

 Today's Must Reads

Microsegmentation: The Future of Cybersecurity?


How this Playboy Playmate Became a Better Stock Trader Than You

Long Term Rates Are On The Up…What’s Next?

The Modern Web: So Many Ways to Invest in Wireless Mobile Stocks

It's Time for the Rest of the Country to Legalize Weed

 

Do you expect a 10% correction by the end of 2015? in Equities.com Polls on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register

LOG IN